To review AI-generated patient messages safely, treat each draft as a starting point, not a message ready to send. A reviewer should confirm that it answers the patient’s actual question, matches reliable information in the chart, stays within the sender’s role, and gives clear next steps. Messages involving symptoms, medication, or treatment decisions need a different path from routine administrative replies.
This is a workflow issue as much as a writing issue. The AMA’s discussion of AI and EHR inbox work offers context for how these tools may support message handling. Your own process should make clear who can edit or reject a draft, when a clinician must step in, and how the team learns from errors.
Set the review path by message risk
Before staff review a draft, they need to know what kind of message it is and what they are authorized to do with it. Create clear categories and routing rules that fit your clinic’s workflows and clinical policies.
- Routine administrative messages: Scheduling details, office logistics, or other approved nonclinical information may be reviewed by trained staff who have permission to respond. Check that the details are correct and that the reply does not drift into clinical advice.
- Clinical questions: Questions about test results, ongoing symptoms, care plans, or medication instructions should go to the appropriate clinical reviewer. Staff should not approve a draft just because it sounds confident or uses familiar language.
- Urgent or potentially serious concerns: A message describing concerning symptoms or a possible immediate risk should follow the clinic’s established escalation process. Do not let an AI draft or routine inbox queue delay that review. For a related workflow, see how urgent cases can be kept out of routine referral queues.
Write these categories into the workflow, including who receives an escalation and what staff should do if they are uncertain. The WHO’s AI ethics and governance guidance and the NIST generative AI risk management profile can inform broader governance discussions, but your local review steps should reflect the actual messages and responsibilities in your setting.
A pre-send checklist for every draft
Use a consistent checklist so reviewers examine the substance of the message, not only its grammar. A simple approval step is not meaningful oversight if the reviewer cannot verify the content or change the draft.
- Confirm the patient and the question. Make sure the message is for the intended patient and that the draft responds to what they actually asked. Check for missed questions, assumptions about their concern, or wording that could be read as dismissive.
- Verify chart-specific details. Compare every patient-specific statement with the appropriate source in the chart. Pay attention to details such as the care plan, appointment information, medication instructions, and relevant dates. If information is missing, inconsistent, or unclear, pause and ask the right team member rather than letting the draft fill in the gap.
- Check clinical claims and recommendations. Confirm that clinical statements are supported by the patient’s documented plan and approved clinical guidance. Look for invented explanations, unsupported reassurance, and recommendations that go beyond what the reviewer is authorized to approve. A polished tone is not evidence that the content is correct.
- Review the next step. The patient should be able to tell what happens next and whom to contact if the issue continues or needs attention. Remove promises about outcomes or timing unless the clinic can support them. If the right next step depends on clinical judgment, route the message for clinician review.
- Check privacy and the recipient. Confirm the recipient and communication channel, and remove details that are not needed to answer the question. Use only tools and workflows approved by the organization for the information being handled. If the destination or permitted use is uncertain, stop and follow the clinic’s privacy process.
- Check tone and readability. Use plain, respectful language. Explain unfamiliar terms when appropriate, avoid unnecessary jargon, and make sure the message does not sound blameful, overly certain, or impersonal. The patient should not have to guess what the message means.
- Make approval accountable. The assigned reviewer must be able to edit or reject the draft, and the workflow should identify who owns final approval for each category. If the reviewer cannot verify a claim or decide whether it is safe to send, escalate instead of approving by default.
Who should review an AI-drafted response?
Assign review based on the content and the person’s role, not simply on who is available in the inbox. Trained administrative staff may handle approved routine information within their responsibilities. Clinical questions should be reviewed by an appropriately qualified clinician under the clinic’s own procedures. Messages that may be urgent need a defined route to timely clinical assessment.
Make it easy for any team member to stop a draft from going out. Staff should know how to flag uncertainty, where to send a message for review, and what to do when the designated reviewer is unavailable. Human oversight works only when reviewers have the authority, time, and information to make a real decision.
Handle errors as workflow signals
If a reviewer finds an error before sending, correct or reject the draft and record the issue through the clinic’s chosen feedback process. If an inaccurate message has already been sent, follow established patient communication and incident procedures rather than relying on an improvised correction.
Look for recurring patterns: for example, drafts that repeatedly use outdated chart details, miss part of the patient’s question, or fail to route a certain kind of clinical concern. Use those findings to adjust review instructions, routing rules, source information, and staff training. The purpose is not just to catch one bad message, but to make the workflow less likely to produce the same problem again.
Decide how to explain AI assistance
Set a consistent approach for telling patients when AI helped prepare a message. Consider how the tool is being used, what your organization’s policies say, and any requirements that apply to your setting. The reviewer remains responsible for checking the message before it is sent; disclosure does not replace that review. Avoid implying that a clinician personally evaluated a draft if that did not happen.
Monitor quality after launch
Review a sample of sent messages over time, including drafts that staff edited, rejected, or escalated. Look at accuracy, whether the message answered the patient’s question, correct routing, privacy handling, and clarity of next steps. Invite staff to report near misses and confusing drafts, then use the feedback to refine the process.
Keep the review rules visible and revisit them when the workflow, approved tools, or message types change. A clinic considering implementation support can learn more about Zevonix’s AI workflow support, which includes AI integration and team training.
Frequently asked questions
Can an AI-generated message recommend a medication or treatment change?
Do not send a treatment change based only on an AI draft. Route medication and treatment questions to the appropriate clinician, who can review the patient’s context and follow the clinic’s procedures.
How can staff check an answer against the patient’s chart?
Identify the chart source relevant to each patient-specific claim, then compare the draft with that source. If details conflict, are missing, or are unclear, do not guess. Request clarification or route the message to the appropriate reviewer.
What should the team do with a draft that contains an error?
Do not send it as written. Correct or reject it, record the issue through the team’s feedback process, and check for similar patterns in other drafts. If the message was already sent, follow the clinic’s established correction and incident procedures.
How often should a clinic review message quality?
Build ongoing review into the workflow rather than treating approval at launch as a permanent check. Review messages and staff feedback regularly, and revisit safeguards when the workflow or tool changes.
Start with a clear review owner
Safe patient messaging depends on a dependable handoff between the AI draft and the person authorized to approve it. Start by assigning an owner for each message category, then use the checklist to test the workflow before expanding its use.